Trial Profile
A Phase III, Double Blind, Parallel-controlled, Randomised Study to Evaluate the Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine in Healthy Children 2 Months to 5 Years of Age
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 04 Sep 2017
Price :
$35
*
At a glance
- Drugs Hib vaccine conjugate-Minhai (Primary) ; Hib vaccine conjugate
- Indications Haemophilus infections
- Focus Pharmacodynamics
- Sponsors Beijing Minhai Biotechnology
- 05 Oct 2015 New trial record